Lifeloc Reports 2021 Full Year Results'

(MENAFN- PR Newswire)

WHEAT RIDGE, Colo., Feb. 22, 2022 /PRNewswire/ -- Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the 2021 fiscal year ended December 31, 2021.

2021 Financial Highlights

Lifeloc Technologies posted annual net revenue of $7.054 million resulting in 2021 after tax profit of $676 thousand, or net income of $0.27 per diluted share. These results compare to net revenue of $6.357 million for 2020, with net loss of $922 thousand, or $(0.38) per diluted share. The 2021 results included a one-time gain of $936 thousand from the forgiveness of both the 2020 and 2021 Paycheck Protection Program loans through the SBA. Revenues for 2021 grew by 11% over 2020 sales, representing a partial recovery to pre-pandemic sales levels.

Lifeloc took advantage of continued low interest rates to secure a stable and low interest rate on our only debt, refinancing our building mortgage on September 30, 2021, replacing the prior 4.00% fixed rate (until October 2024) mortgage with a 2.95% mortgage fixed until September 2031. This refinancing was immediately cash flow positive, with all refinance costs to be recovered through interest savings by early 2023, while eliminating the significant 2024 interest rate change risk from the prior mortgage.

New platform LX9 and LT7 devices produced sales growth of 65% in 2021 versus 2020. The features and performance of the new L-series products have driven penetration by meeting previously unaddressable market needs, such as wider temperature ranges and fast customization that incorporates local languages. We expect that most L-series sales will be incremental to FC-series devices rather than displacing FC sales. The L-series devices are meeting the requirements of the most modern registration standards, such as SAI's (Standards Australia International) latest AS 3547:2019 standards for Breath Alcohol Detectors.

We continue to invest in the significant growth opportunities of alcohol monitoring and drug detection. The monitoring opportunity will be addressed primarily through the redesigned Real-Time Alcohol Detection and Reporting (R.A.D.A.R.®) device. Field testing of the redesigned R.A.D.A.R. 200 devices and integration with the monitoring system has been extensive and has required additional modifications before final release. The design has now been completed with several devices field tested by key customers and now has been released to sales. Several upgrades have been made to the reporting system including migration to the cloud for higher reliability and an entirely new enrollment app to automate the enrollment process.

Our most important goal remains the convergence of the global need for rapid detection of drugs of abuse with Lifeloc's capability of building easy-to-use portable testing equipment. We intend to use the SpinDx™ technology platform, sometimes referred to as 'Lab on a Disk', to develop a series of devices and tests that could be used at roadside, emergency rooms and in workplace testing to get a rapid and quantitative measure for a panel of drugs of abuse. The first test we intend to offer is the SpinDx device with disks for delta-9-THC detection from an oral fluid sample collected from a test subject. Then we intend to offer a device based on our recently updated LX9 breathalyzer to collect a sample for analysis from breath, which coupled with the SpinDx device will be our marijuana breathalyzer system. We have improved the detection sensitivity for delta-9-THC as well as the robustness of the device. We are continuing to work on developing this system into a device that can be used for roadside testing, as well as other contexts requiring fast response. Additional personnel and new equipment resources have been committed to finalizing the development of the first products of the SpinDx technology platform.

'We saw some sales recovery in 2021 and we expect to see more in 2022, with many customers having deferred new equipment purchases during the pandemic,' commented Dr. Wayne Willkomm, President and CEO. 'However, we are not just relying on pent up demand for sales growth, but instead our strong pipeline of recent and upcoming product releases will be the big driver. The Easycal® calibration station and the premium L-series devices are finding broad acceptance and the R.A.D.A.R. 200 devices have been released to sales. Revenue from these will all provide the continued funding to push the SpinDx product platform across the finish line to commercialization. We will see research and development expenses continue to rise in this final push, prioritizing substantial value creation over short-term profitability. We are hopeful that the SpinDx platform will begin making a revenue contribution by late 2022.'

About Lifeloc Technologies

Lifeloc Technologies, Inc. (OTC: LCTC) is a trusted U.S. manufacturer of evidential breath alcohol testers and related training and supplies for Workplace, Law Enforcement, Corrections and International customers. Lifeloc stock trades over-the-counter under the symbol LCTC. We are a fully reporting Company with our SEC filings available on our web site, .

Forward Looking Statements

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which involve substantial risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. All forward-looking statements expressed or implied in this press release, including statements about our strategies, expectations about new and existing products, market demand, acceptance of new and existing products, technologies and opportunities, market size and growth, and return on investments in products and market, are based on information available to us on the date of this document, and we assume no obligation to update such forward-looking statements. Investors are strongly encouraged to review the section titled 'Risk Factors' in our SEC filings .

Easycal® and R.A.D.A.R.® are registered trademarks of Lifeloc Technologies, Inc.

SpinDx™ is a trademark of Sandia Corporation.

Amy Evans Lifeloc Technologies, Inc. (303) 431-9500

LIFELOC TECHNOLOGIES, INC.
Balance Sheets

ASSETS


			December 31,
CURRENT ASSETS:		2021		2020
	Cash	$	2,571,668	$	2,195,070
	Accounts receivable, net		562,092		523,603
	Inventories, net		2,668,789		2,498,126
	Income taxes receivable		0		220,657
	Prepaid expenses and other		56,897		77,962
	Total current assets		5,859,446		5,515,418

PROPERTY AND EQUIPMENT, at cost:
	Land		317,932		317,932
	Building		1,928,795		1,928,795
	Real-time Alcohol Detection And Recognition equipment and software		569,448		569,448
	Production equipment, software and space modifications		958,785		958,785
	Training courses		432,375		432,375
	Office equipment, software and space modifications		216,618		216,618
	Sales and marketing equipment and space modifications		226,356		226,356
	Research and development equipment, software and space modifications		456,685		190,818
	Less accumulated depreciation		(2,518,966)		(2,277,839)
	Total property and equipment, net		2,588,028		2,563,288

OTHER ASSETS:
	Patents, net		134,428		144,702
	Deposits and other		163,480		164,798
	Deferred taxes		204,449		148,142
	Total other assets		502,357		457,642

	Total assets	$	8,949,831	$	8,536,348

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
	Accounts payable	$	445,985	$	333,851
	Term loan payable, current portion		48,513		46,936
	Paycheck Protection Program loan payable		-		465,097
	Customer deposits		170,952		155,295
	Accrued expenses		298,530		266,266
	Deferred revenue, current portion		71,604		41,053
	Reserve for warranty expense		46,500		46,500
	Total current liabilities		1,082,084		1,354,998

TERM LOAN PAYABLE, net of current portion and debt issuance costs		1,267,551		1,277,531

DEFERRED REVENUE, net of current portion		6,430		3,177
	Total liabilities		2,356,065		2,635,706


COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY:
	Common stock, no par value; 50,000,000 shares authorized, 2,454,116 shares outstanding		4,650,812		4,633,655
	Retained earnings		1,942,954		1,266,987
	Total stockholders' equity		6,593,766		5,900,642

	Total liabilities and stockholders' equity	$	8,949,831	$	8,536,348

LIFELOC TECHNOLOGIES, INC.
Statements of Income

		Years Ended December 31,
REVENUES:		2021			2020
	Product sales	$	6,898,955		$	6,122,348
	Royalties		67,526			148,398
	Rental income		87,949			85,956
	Total		7,054,430			6,356,702

COST OF SALES		3,994,334			4,176,156

GROSS PROFIT		3,060,096			2,180,546

OPERATING EXPENSES:
	Research and development		1,213,482			1,007,297
	Sales and marketing		1,003,983			1,074,249
	General and administrative		1,111,544			1,254,503
	Total		3,329,009			3,336,049

OPERATING INCOME (LOSS)		(268,913)			(1,155,503)

OTHER INCOME (EXPENSE):
	Forgiveness of Paycheck Protection loan		936,444			-
	Interest income		3,401			14,294
	Interest expense		(51,272)			(56,129)
	Total		888,573			(41,835)

NET INCOME (LOSS) BEFORE PROVISION FOR TAXES		619,660			(1,197,338)

BENEFIT FROM (PROVISION FOR) FEDERAL AND STATE INCOME TAXES		56,307			275,408

NET INCOME (LOSS)	$	675,967		$	(921,930)

NET INCOME (LOSS) PER SHARE, BASIC	$	0.28		$	(0.38)

NET INCOME (LOSS) PER SHARE, DILUTED	$	0.27		$	(0.38)

WEIGHTED AVERAGE SHARES, BASIC		2,454,116			2,454,116

WEIGHTED AVERAGE SHARES, DILUTED		2,518,895			2,454,116

Lifeloc Technologies, Inc.
Statements of Stockholders' Equity


		Years Ended December 31,
		2021		2020
Total stockholders' equity, beginning balances	$	5,900,642		$	6,792,221

Common stock (no shares issued during periods):
	Beginning balances		4,633,655			4,603,304
	Stock based compensation expense related to stock options		17,157			30,351
	Ending balances		4,650,812			4,633,655

Retained earnings:
	Beginning balances		1,266,987			2,188,917
	Net income (loss)		675,967			(921,930)
	Ending balances		1,942,954			1,266,987

Total stockholders' equity, ending balances	$	6,593,766		$	5,900,642

LIFELOC TECHNOLOGIES, INC.
Statements of Cash Flows

			Years Ended December 31,
CASH FLOWS FROM OPERATING ACTIVITIES:	2021		2020
	Net income (loss)	$	675,967		$	(921,930)
	Adjustments to reconcile net income (loss) to net cash provided from operating activities-
	Forgiveness of Paycheck Protection loans		(936,444)			-
	Depreciation and amortization		254,823			364,336
	Provision for doubtful accounts, net change	(49,000)			24,000
	Provision for inventory obsolescence, net change		(5,000)			20,000
	Deferred taxes, net change		(56,307)			(61,484)
	Reserve for warranty expense, net change		-			1,500
	Stock based compensation expense related to stock options		17,157			30,351
	Changes in operating assets and liabilities-
	Accounts receivable		10,511			93,636
	Inventories		(165,663)			(531,827)
	Income taxes receivable		220,657			(213,907)
	Prepaid expenses and other		21,065			(59,105)
	Deposits and other		1,318			(90,771)
	Accounts payable		112,134			72,053
	Customer deposits		15,657			(58,736)
	Accrued expenses		32,264			(24,192)
	Deferred revenue		33,804			(7,710)
		Net cash provided from (used in) operating activities		182,943			(1,363,786)

CASH FLOWS FROM INVESTING ACTIVITIES:
	Purchases of property, equipment and space modifications	(265,867)			(27,477)
	Patent filing expense		(2,609)			(18,796)
		Net cash (used in) investing activities		(268,476)			(46,273)

CASH FLOWS FROM FINANCING ACTIVITIES:
	Principal payments made on term loans		(1,341,059)			(45,964)
	Proceeds from refinancing term loan		1,350,000			-
	Cost of refinancing term loan		(18,157)			-
	Proceeds from Paycheck Protection loan		471,347			465,097
		Net cash provided from (used in) financing activities		462,131			419,133

NET INCREASE (DECREASE) IN CASH		376,598			(990,926)

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD		2,195,070			3,185,996

CASH AND CASH EQUIVALENTS, END OF PERIOD	$	2,571,668		$	2,195,070

SUPPLEMENTAL INFORMATION:
	Cash paid for interest	$	50,458		$	55,045

SOURCE Lifeloc Technologies

MENAFN22022022003732001241ID1103747305

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.